Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

Kilwinning roadworks alert as 'frustrating' disruption set to last for one month

Roads to be dug up as a result of cabling work.

Daily Record

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market

Moderna stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

StockNews.com

GSK facing months of industrial action as workers go on strike at pharma giant

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

Daily Record

GSK to move back to central London with new HQ

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

Evening Standard

Moonpig flotation price, like so many, was always pie-in-the-sky thinking

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

GSK shares surge as US judge dismisses Zantac cancer claims

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Guardian - UK

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review

The stock market rally tumbled after Fed chief Powell signaled a higher peak rate. The jobs report and heavy earnings also swung stocks.

Investors Business Daily

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth

Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line.

Investors Business Daily

Mark Zuckerberg’s metaverse is a joke not shared by investors

Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course

The Guardian - UK

GSK Slips As Shingles Vaccine Drives Commanding Third-Quarter Beat

GSK stock jumped Wednesday after the company beat third-quarter forecasts due to strength from specialty medicines and Shingrix.

Investors Business Daily

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

Wales Online

Gareth Thomas thanks ViiV for support in fight against HIV stigma

Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour.

The Guardian - UK

‘A better partner’: Labour woos big business in bid to oust Rishi Sunak

Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election

StockNews.com

3 Upgraded Stocks to Consider Buying This Week

The red-hot inflation is increasing the odds of continued rate hikes by the Fed. Since the market is expected to remain under pressure on recession fears, it could be wise to invest in fundamentally sound stocks Comcast Corporation (CMCSA), GSK (GSK), and Masonite International (DOOR), which have been recently upgraded…

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

GSK vaccine shows ‘exceptional’ efficacy against common lung infection RSV

The pharmaceutical giant’s vaccine was found to be 82.6 per cent effective in Phase III clinical trials

Benzinga

Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13

Reuters

The Conversation

Pollen does more than make you sneeze. It can cause thunderstorm asthma, even if you're not asthmatic

Climate change has caused melting icebergs, flooding, and landslides. It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems.

Wales Online

Eamonn Holmes shares details of 'ghastly' health scare

Television presenter calls for more awareness and understanding to fight the illness

Daily Mirror

Questions you should ask your GP if you're concerned about your periods and gynae problems

Research shows one in four people have felt not listened to in a gynae health appointment - checklist shows how you can prepare for GP appointments so it feels less daunting

Benzinga

Bloomberg

Benzinga

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations